Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Dérivé de l'oxazaphosphinane")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 837

  • Page / 34
Export

Selection :

  • and

Effect of taurine on leucocyte functionLEI WANG; NA ZHAO; FANG ZHANG et al.European journal of pharmacology. 2009, Vol 616, Num 1-3, pp 275-280, issn 0014-2999, 6 p.Article

Long term renal toxicity of ifosfamide in adult patients ― 5 year dataFARRY, James K; FLOMBAUM, Carlos D; LATCHA, Sheron et al.European journal of cancer (1990). 2012, Vol 48, Num 9, pp 1326-1331, issn 0959-8049, 6 p.Article

Diastereoselective Michael addition of 2H-2-oxo-1,4,2-oxaza phosphinanes to olefinsMONBRUN, Jérôme; DAYDE, Bénédicte; CRISTAU, Henri-Jean et al.Tetrahedron (Oxford. Print). 2011, Vol 67, Num 2, issn 0040-4020, 283, 540-545 [7 p.]Article

Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapyCHINNASWAMY, Girish; ERRINGTON, Julie; FOOT, Annabel et al.European journal of cancer (1990). 2011, Vol 47, Num 10, pp 1556-1563, issn 0959-8049, 8 p.Article

Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to CyclophosphamideMOSCHELLA, Federica; VALENTINI, Mara; ARICO, Eleonora et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 10, pp 3528-3539, issn 0008-5472, 12 p.Article

Conjunctival lymphoma following treatment with cyclophosphamideLORIDON, N. J. S; SIVERIO, C; CUNNINGHAM, E. T et al.Eye (London. 1987). 2010, Vol 24, Num 7, pp 1294-1295, issn 0950-222X, 2 p.Article

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organsNAKAHARA, Takeshi; UCHI, Hiroshi; LESOKHIN, Alexander M et al.Blood. 2010, Vol 115, Num 22, pp 4384-4392, issn 0006-4971, 9 p.Article

Dominant Effect of Antiangiogenesis in Combination Therapy Involving Cyclophosphamide and AxitinibJIE MA; WAXMAN, David J.Clinical cancer research (Print). 2009, Vol 15, Num 2, pp 578-588, issn 1078-0432, 11 p.Article

Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in ChildrenOBERLIN, Odile; FAWAZ, Oumaya; RUBIE, Hervé et al.Journal of clinical oncology. 2009, Vol 27, Num 32, pp 5350-5355, issn 0732-183X, 6 p.Article

Personalized Dosing of Cyclophosphamide in theTotal Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic MalignancyMCCUNE, J. S; BATCHELDER, A; GUTHRIE, K. A et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 6, pp 615-622, issn 0009-9236, 8 p.Article

The Immunoregulatory Roles of Natural Killer T Cells in Cyclophosphamide-Induced ToleranceIWAI, Toshiro; TOMITA, Yukihiro; SHIMIZU, Ichiro et al.Transplantation. 2007, Vol 84, Num 12, pp 1686-1695, issn 0041-1337, 10 p.Article

The effect of N-acetylcysteine on the antitumor activity of ifosfamideCHEN, Nancy; HANLY, Lauren; RIEDER, Michael et al.Canadian journal of physiology and pharmacology. 2011, Vol 89, Num 5, pp 335-343, issn 0008-4212, 9 p.Article

Immunomodulatory effects of cyclophosphamide and implementations for vaccine designSISTIGU, Antonella; VIAUD, Sophie; CHAPUT, Nathalie et al.Seminars in immunopathology (Print). 2011, Vol 33, Num 4, pp 369-383, issn 1863-2297, 15 p.Article

Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2KOTTKE, Timothy; THOMPSON, Jill; DIAZ, Rosa Maria et al.Clinical cancer research (Print). 2009, Vol 15, Num 2, pp 561-569, issn 1078-0432, 9 p.Article

Effect of melatonin on apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatmentZUPANCIC, Dasa; JEZERNIK, Kristijan; VIDMAR, Gaj et al.Journal of pineal research. 2008, Vol 44, Num 3, pp 299-306, issn 0742-3098, 8 p.Article

Cyclophosphamide for Ocular Inflammatory DiseasesPUJARI, Siddharth S; KEMPEN, John H; ROSENBAUM, James T et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 2, pp 356-365, issn 0161-6420, 10 p.Article

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumorsSHIMIZU, Toshio; OKAMOTO, Isamu; TAMURA, Kenji et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 5, pp 243-250, issn 0344-5704, 8 p.Article

Selective Depletion of CD4+CD25+Foxp3+ Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP LevelsJIE ZHAO; YUCHUN CAO; ZHANG LEI et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 12, pp 4850-4858, issn 0008-5472, 9 p.Article

Influence of Hyperglycaemia on Chemical-Induced Toxicity: Study with Cyclophosphamide in RatSAANDEEP, Kalavatala; VIKRAM, Ajit; NAND TRIPATHI, Durga et al.Basic & clinical pharmacology & toxicology (Print). 2009, Vol 105, Num 4, pp 236-242, issn 1742-7835, 7 p.Article

Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of ReovirusJIAN QIAO; HONGXUN WANG; PANDHA, Hardev et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 259-269, issn 1078-0432, 11 p.Article

Occupational Exposure to Cyclophosphamide in Nurses at a Single CenterRAMPHAL, Raveena; BAINS, Tejinder; VAILLANCOURT, Régis et al.Journal of occupational and environmental medicine. 2014, Vol 56, Num 3, pp 304-312, issn 1076-2752, 9 p.Article

Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current PerspectiveLE, Dung T; JAFFEE, Elizabeth M.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 14, pp 3439-3444, issn 0008-5472, 6 p.Article

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumorsSHIMIZU, Toshio; OKAMOTO, Isamu; TAMURA, Kenji et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 2, pp 243-250, issn 0344-5704, 8 p.Article

Stability of Cyclophosphamide in Extemporaneous Oral SuspensionsKENNEDY, Rachel; GROEPPER, Daniel; TAGEN, Michael et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 2, pp 295-301, issn 1060-0280, 7 p.Article

Ipomoea obscura ameliorates cyclophosphamide-induced toxicity by modulating the immune system and levels of proinflammatory cytokine and GSHHAMSA, T. P; KUTTAN, Girija.Canadian journal of physiology and pharmacology. 2010, Vol 88, Num 11, pp 1042-1053, issn 0008-4212, 12 p.Article

  • Page / 34